ITEM VIEW

Prophylactic human papillomavirus vaccination against cervical cancer : a summarised resource for clinicians

dc.contributor.authorLindeque, B. G.en_ZA
dc.contributor.authorDreyer, G.en_ZA
dc.contributor.authorBotha, M. H.en_ZA
dc.contributor.authorMoodley, T.en_ZA
dc.contributor.authorSoeters, R.en_ZA
dc.contributor.authorSmith, T.en_ZA
dc.contributor.authorCooreman, B.en_ZA
dc.contributor.authorGuidozzi, F.en_ZA
dc.contributor.authorHoosen, A.en_ZA
dc.contributor.authorMouton, A.en_ZA
dc.contributor.authorTurner, A.en_ZA
dc.contributor.authorKoller, T.en_ZA
dc.contributor.authorMoodley, J.en_ZA
dc.contributor.authorWhittaker, R. J.en_ZA
dc.contributor.authorWilliamson, A.en_ZA
dc.contributor.authorRogers, L.en_ZA
dc.contributor.authorSouth African Human Papillomavirus Advisory Boarden_ZA
dc.date.accessioned2012-08-10T21:05:07Z
dc.date.available2012-08-10T21:05:07Z
dc.date.issued2011
dc.identifier.citationLindeque, B. G. et al. Prophylactic human papillomavirus vaccination against cervical cancer : a summarised resource for clinicians. Southern African Journal of Gynaecological Oncology, 3(1):39-42.
dc.identifier.issn2220-105X (online)
dc.identifier.issn2074-2835 (print)
dc.identifier.urihttp://hdl.handle.net/10019.1/43789
dc.descriptionCITATION: Lindeque, B. G. et al. Prophylactic human papillomavirus vaccination against cervical cancer : a summarised resource for clinicians. Southern African Journal of Gynaecological Oncology, 3(1):39-42.
dc.descriptionThe original publication is available at http://www.sajgo.co.za
dc.description.abstractCarcinoma of the cervix remains the most frequent cancer affecting women in South Africa. Twenty-three per cent of all reported cancers in women are of the uterine cervix. Cancer of the cervix resulted in an estimated 3 700 deaths in South Africa during 2002. The human papillomavirus (HPV) has been proven a potent carcinogen. The aetiological role of HPV infection in the development of preinvasive and invasive lesions of the cervix, vagina and the anogenital region has been conclusively established. Vaccination against infection with specific high-risk HPV is commercially available, and is likely to change the future of the disease.
dc.description.urihttp://www.sajgo.co.za/index.php/sajgo/article/view/60
dc.format.extent4 pages
dc.language.isoen
dc.publisherSouth African Society of Gynaecologic Oncology
dc.subjectPapillomavirus diseasesen_ZA
dc.subjectCervix uteri -- Canceren_ZA
dc.titleProphylactic human papillomavirus vaccination against cervical cancer : a summarised resource for cliniciansen_ZA
dc.typeArticle
dc.description.versionPublisher's version
dc.rights.holderSouth African Society of Gynaecologic Oncology


Files in this item

Thumbnail

This item appears in the following Collection(s)

ITEM VIEW